Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹305 Cr
Revenue (TTM)
₹203 Cr
Net Profit (TTM)
₹-4 Cr
ROE
-0.9 %
ROCE
-0.4 %
P/E Ratio
--
P/B Ratio
1
Industry P/E
33.74
EV/EBITDA
64.6
Div. Yield
0 %
Debt to Equity
0.5
Book Value
₹57.1
EPS
₹-0.7
Face value
10
Shares outstanding
54,312,500
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Valiant Lab
| -18.3 | -0.2 | -16.9 | -22.4 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Valiant Lab
| -32.4 | -36.6 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Valiant Lab
|
57.2 | 305.1 | 203.3 | -4.3 | 0.9 | -1.6 | -- | 1.0 |
| 352.7 | 3,213.2 | 2,521.8 | 202.5 | 9.6 | 14.3 | 15.9 | 2.1 | |
| 989.6 | 12,119.0 | 2,512.3 | 543.7 | 28.3 | 19.3 | 22.3 | 3.8 | |
| 357.4 | 6,190.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 21.1 | 4.8 | |
| 1,025.1 | 10,733.1 | 1,158.7 | 309.6 | 31.9 | 17.3 | 34.3 | 5.7 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 12,433.0 | 15,953.0 | 1,575.1 | 179.1 | 14.9 | 11.4 | 89.1 | 9.6 | |
| 784.3 | 3,617.1 | 588.5 | 102.9 | 22.1 | 12.7 | 35.6 | 4.3 | |
| 615.1 | 6,946.9 | 502.0 | 138.7 | -- | 32.8 | 50.1 | 8.0 | |
| 158.0 | 4,151.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 6.2 |
4 min read•By Satyajit Sen
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States... pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP. Read more
Incorporated
2021
Chairman
--
Managing Director
Santosh S Vora
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Valiant Laboratories Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Valiant Laboratories Ltd is ₹57.19 (NSE) and ₹56.18 (BSE) as of 02-Apr-2026 IST. Valiant Laboratories Ltd has given a return of -22.41% in the last 1 years.
Since, TTM earnings of Valiant Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Valiant Laboratories Ltd is 0.98 times as on 02-Apr-2026, a 54 discount to its peers’ median range of 2.13 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.42
|
|
2024
|
1,837.23
|
2.67
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
1.42
|
|
2024
|
1,837.23
|
2.67
|
The 52-week high and low of Valiant Laboratories Ltd are Rs 115.54 and Rs 49.51 as of 04-Apr-2026.
Valiant Laboratories Ltd has a market capitalisation of ₹ 305 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Valiant Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.25
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.